✦ LIBER ✦

Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease

✍ Scribed by Laura A Dawson; Naoyuki G Saito; Voravit Ratanatharathorn; Joseph P Uberti; Paul T Adams; Lois J Ayash; Christopher M Reynolds; Samuel M Silver; Matthew J Schipper; Allen S Lichter; Avraham Eisbruch

Book ID: 108148260
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 206 KB
Volume: 59
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2003.07.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Consolidative involved field radiotherap

Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study

✍ Christoph Oehler-Jänne; Christian Taverna; Nadine Stanek; Laura Negretti; Urs M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract The role of involved field radiation therapy (IF‐RT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for non‐Hodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IF‐RT. A

Study of conditioning regimens with or w

Study of conditioning regimens with or without high-dose radiotherapy before autologous stem cell transplantation for treating aggressive lymphoma

✍ Yi Niu; Yuankai Shi; Shengyu Zhou; Feng Pan; Shikai Wu; Peng Liu; Jiangliang Yan 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 209 KB

Does the Addition of Involved Field Radi

Does the Addition of Involved Field Radiotherapy to High-dose Chemotherapy and Stem Cell Transplantation Improve Outcomes for Patients with Relapsed/Refractory Hodgkin Lymphoma?

✍ Kahn, S.T.; Flowers, C.; Xu, Z.; Esiashvili, N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase-I–II study of high-dose melphalan

Phase-I–II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas

✍ B. Mascret; D. Maraninchi; J. A. Gastaut; D. Baume; G. Sebahoun; C. Lejeune; G. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 587 KB

Multicenter study of intravenous busulfa

Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma

✍ Kim, J G; Sohn, S K; Chae, Y S; Yang, D H; Lee, J-J; Kim, H-J; Shin, H J; Jung, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Disease staging with positron emission t

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation

✍ Amin M. Alousi; Rima M. Saliba; Grace-Julia Okoroji; Homer A. Macapinlac; Chitra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB